Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_assertion type Assertion NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_head.
- NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_assertion description "[Based in part on these data, PKC412 was administered to a patient with t(8;13)(p11;q12) and was efficacious in treatment of progressive myeloproliferative disorder with organomegaly.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_provenance.
- NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_assertion evidence source_evidence_literature NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_provenance.
- NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_assertion SIO_000772 15448205 NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_provenance.
- NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_assertion wasDerivedFrom befree-20140225 NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_provenance.
- NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_assertion wasGeneratedBy ECO_0000203 NP366899.RA0Tt0N42RlEB4WKZGdh1yft24BmDTrNlk34Ys8WgFpE4130_provenance.